Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New NHE-1 inhibitor with cardioprotective effects in myocardial stunning presented to AHA

Nov. 14, 2000

AHA news: termination of supraventicular tachycardia by CVT-510

Nov. 14, 2000

UT-15 to be reviewed by FDA advisory committee; promising clinical data reported

Nov. 14, 2000

Selective cGMP-PDE inhibitors synthesized at Nippon Soda

Nov. 13, 2000

First clinical trial begins for novel HDL therapy

Nov. 13, 2000

In vivo interactions between coronary vasodilators S-nitrosocaptopril and nitroglycerin

Nov. 10, 2000

Forest to market Recordati's lercanidipine in U.S.

Nov. 10, 2000

Merck issued patent covering new anticoagulants

Nov. 8, 2000

SBIR grant awarded to MetaPhore for human septic shock study

Nov. 8, 2000

Medicure licenses cardiovascular therapeutics from George Washington University

Nov. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...